Suppr超能文献

隐匿性血尿与肉眼血尿和膀胱癌风险:一项初级医疗电子记录研究

Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care.

作者信息

Price Sarah J, Shephard Elizabeth A, Stapley Sally A, Barraclough Kevin, Hamilton William T

机构信息

University of Exeter Medical School, Exeter.

Hoyland House General Practice, Painswick, Gloucestershire.

出版信息

Br J Gen Pract. 2014 Sep;64(626):e584-9. doi: 10.3399/bjgp14X681409.

Abstract

BACKGROUND

Diagnosis of bladder cancer relies on investigation of symptoms presented to primary care, notably visible haematuria. The importance of non-visible haematuria has never been estimated.

AIM

To estimate the risk of bladder cancer with non-visible haematuria.

DESIGN AND SETTING

A case-control study using UK electronic primary care medical records, including uncoded data to supplement coded records.

METHOD

A total of 4915 patients (aged ≥40 years) diagnosed with bladder cancer between January 2000 and December 2009 were selected from the Clinical Practice Research Datalink and matched to 21 718 controls for age, sex, and practice. Variables for visible and non-visible haematuria were derived from coded and uncoded data. Analyses used multivariable conditional logistic regression, followed by estimation of positive predictive values (PPVs) for bladder cancer using Bayes' theorem.

RESULTS

Non-visible haematuria (coded/uncoded data) was independently associated with bladder cancer: odds ratio (OR) 20 (95% confidence interval [CI] =12 to 33). The PPV of non-visible haematuria was 1.6% (95% CI = 1.2 to 2.1) in those aged ≥60 years and 0.8% (95% CI = 0.1 to 5.6) in 40-59-year-olds. The PPV of visible haematuria was 2.8% (95% CI = 2.5 to 3.1) and 1.2% (95% CI = 0.6 to 2.3) for the same age groups respectively, lower than those calculated using coded data alone. The proportion of records of visible haematuria in coded, rather than uncoded, format was higher in cases than in controls (P<0.002, χ(2) test). There was no evidence for such differential recording of non-visible haematuria by case/control status (P = 0.78), although, overall, the uncoded format was preferred (P<0.001).

CONCLUSION

Both non-visible and visible haematuria are associated with bladder cancer, although the visible form confers nearly twice the risk of cancer compared with the non-visible form. GPs' style of record keeping varies by symptom and possible diagnosis.

摘要

背景

膀胱癌的诊断依赖于对基层医疗中出现的症状进行调查,尤其是肉眼血尿。隐匿性血尿的重要性从未得到评估。

目的

评估隐匿性血尿患者患膀胱癌的风险。

设计与研究地点

一项利用英国电子基层医疗病历进行的病例对照研究,包括使用未编码数据来补充编码记录。

方法

从临床实践研究数据链中选取2000年1月至2009年12月期间诊断为膀胱癌的4915名患者(年龄≥40岁),并按照年龄、性别和医疗机构与21718名对照进行匹配。肉眼血尿和隐匿性血尿的变量来自编码和未编码数据。分析采用多变量条件逻辑回归,随后使用贝叶斯定理估计膀胱癌的阳性预测值(PPV)。

结果

隐匿性血尿(编码/未编码数据)与膀胱癌独立相关:比值比(OR)为20(95%置信区间[CI]=12至33)。≥60岁人群中隐匿性血尿的PPV为1.6%(95%CI=1.2至2.1),40-59岁人群中为0.8%(95%CI=0.1至5.6)。相同年龄组中肉眼血尿的PPV分别为2.8%(95%CI=2.5至3.1)和1.2%(95%CI=0.6至2.3),低于仅使用编码数据计算得出的结果。病例组中编码格式而非未编码格式的肉眼血尿记录比例高于对照组(P<0.002,χ²检验)。尽管总体上未编码格式更受青睐(P<0.001),但没有证据表明病例/对照状态对隐匿性血尿的记录存在这种差异(P=0.78)。

结论

隐匿性血尿和肉眼血尿均与膀胱癌相关,尽管肉眼血尿形式相比隐匿性血尿形式患癌风险几乎高出一倍。全科医生的记录方式因症状和可能的诊断而异。

相似文献

2
Clinical features of bladder cancer in primary care.初级保健中的膀胱癌临床特征。
Br J Gen Pract. 2012 Sep;62(602):e598-604. doi: 10.3399/bjgp12X654560.
6
Bladder cancer: microscopic haematuria associated with increased risk.膀胱癌:镜下血尿与风险增加相关。
Nat Rev Urol. 2014 Nov;11(11):606. doi: 10.1038/nrurol.2014.271. Epub 2014 Sep 23.

引用本文的文献

本文引用的文献

5
Clinical features of bladder cancer in primary care.初级保健中的膀胱癌临床特征。
Br J Gen Pract. 2012 Sep;62(602):e598-604. doi: 10.3399/bjgp12X654560.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验